India Drug Delivery Devices Market Size, Share, 2025-2033

The new report by IMARC Group, "India Drug Delivery Devices Market Size, Share, Trends and Forecast by Route of Administration, Application, End User, and Region, 2025-2033", provides an in-depth analysis of The India drug delivery devices market size stood at USD 9.36 Billion in 2024. Going forward, IMARC Group expects the market to reach USD 15.31 Billion by 2033, growing at a CAGR of 5.62% during 2025-2033.

India Drug Delivery Devices Market Overview

The Indian drug delivery devices market is presently witnessing significant growth, with an anticipated upward trend through 2033. This growth is largely because of the advances in drug delivery technologies and rising healthcare needs. The market is driven by the rising need for effective and efficient drug delivery solutions, along with government support initiatives. The horizon is going to expand further with more foreign investment in India's medical device sector, complementing the efforts towards improving healthcare infrastructure in the country.

Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 9.36 Billion
Market Forecast in 2033: USD 15.31 Billion
Market Growth Rate (CAGR): 5.62% (2025-2033)

Request For Sample Report: https://www.imarcgroup.com/india-drug-delivery-devices-market/requestsample

India Drug Delivery Devices Market Trends & Drivers

Technological advancements are one of the major trends influencing the India drug delivery devices market. Intelligent drug delivery systems, integrating digital health monitoring with accurate medication delivery, are gaining traction. Non-invasive delivery devices, for patient comfort, are gaining popularity because of their ease of use and effectiveness. Personalized medicine is becoming increasingly popular, with drug delivery devices being customized to address the specific needs of individual patients, ultimately enhancing treatment outcomes and patient compliance.

The India drug delivery devices market is largely spurred by a number of major factors. Domestic manufacturing and research-promoting government policies are creating a supportive business environment for device manufacturers. The growing incidence of chronic diseases, notably diabetes and cardiovascular diseases, is boosting the demand for sophisticated drug delivery technology. Further, advances in healthcare infrastructure and strategic investments by overseas medical device firms are facilitating quicker uptake of next-generation drug delivery solutions, propelling the market into long-term growth.

Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/india-drug-delivery-devices-market

India Drug Delivery Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on route of administration, application, and end user.

Route of Administration Insights:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on route of administration, application, and end user.

Route of Administration Insights:
Injectable
Topical
Ocular
Others

Application Insights:
· Cancer
· Cardiovascular
· Diabetes
· Infectious Diseases
· Others

End User Insights:
· Hospitals
· Ambulatory Surgical Centers
· Others

Regional Insights:
· North India
· South India
· East India
· West India

India Drug Delivery Devices Market News:

· December 2024: Cipla received approval from CDSCO for sales and distribution of inhaled insulin in India, offering the choice of a needle-free option for diabetic patients.This innovation opens the horizon of pulmonary drug delivery to enhance patient compliance and convenience. Launch of such innovative products adds strength to India's drug delivery business by enhancing adoption of technology as well as regulation.

· November 2024: AptarGroup inaugurated a new pharmaceutical facility in Taloja, close to Mumbai, to encourage local manufacturing of innovations such as pressurized metered dose inhaler (pMDI) valves, breath-actuated devices, and single-dose nasal sprays. The action boosts India's drug delivery devices sector by increasing local manufacturing capacity and allowing Indian pharma companies to launch nasal sprays and inhalers in domestic and global markets.

Key highlights of the Report:

1. Market Performance (2019-2024)
2. Market Outlook (2025-2033)
3. COVID-19 Impact on the Market
4. Porter's Five Forces Analysis
5. Strategic Recommendations
6. Historical, Current and Future Market Trends
7. Market Drivers and Success Factors
8. SWOT Analysis
9. Structure of the Market
10. Value Chain Analysis
11. Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Ask analyst for your customized sample: https://www.imarcgroup.com/request?type=report&id=31349&flag=E

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.